A mitochondrial-focused genetic interaction map reveals a scaffold-like complex required for inner membrane organization in mitochondria

…, A Cassidy-Stone, E Hummel, RM DeVay… - Journal of Cell …, 2011 - rupress.org
To broadly explore mitochondrial structure and function as well as the communication of
mitochondria with other cellular pathways, we constructed a quantitative, high-density genetic …

Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusion

RM DeVay, L Dominguez-Ramirez, LL Lackner… - Journal of cell …, 2009 - rupress.org
Two dynamin-related protein (DRP) families are essential for fusion of the outer and inner
mitochondrial membranes, Fzo1 (yeast)/Mfn1/Mfn2 (mammals) and Mgm1 (yeast)/Opa1 (…

[HTML][HTML] Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9

J Chaparro-Riggers, H Liang, RM DeVay, L Bai… - Journal of Biological …, 2012 - ASBMB
Target-mediated clearance and high antigen load can hamper the efficacy and dosage of
many antibodies. We show for the first time that the mouse, cynomolgus, and human cross-…

Local effects of human PCSK9 on the atherosclerotic lesion

…, AS Major, L Ding, Y Zhang, RM DeVay… - The Journal of …, 2016 - Wiley Online Library
Proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) promotes atherosclerosis by increasing
low‐density lipoprotein ( LDL ) cholesterol levels through degradation of hepatic LDL …

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE-and LDLR-mediated mechanisms

…, D Plubell, A Shivinsky, J Miles, RM Devay… - Cardiovascular …, 2016 - academic.oup.com
Aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of
hepatic low-density lipoprotein (LDL) receptors (LDLR), thereby, decreasing hepatocyte LDL-…

[HTML][HTML] Characterization of proprotein convertase subtilisin/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like …

RM DeVay, DL Shelton, H Liang - Journal of Biological Chemistry, 2013 - ASBMB
Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates low density lipoprotein
receptor protein levels by diverting it to lysosomes. Monoclonal antibody therapeutics aimed to …

Improved lysosomal trafficking can modulate the potency of antibody drug conjugates

RM DeVay, K Delaria, G Zhu, C Holz… - Bioconjugate …, 2017 - ACS Publications
Antibody drug conjugates (ADCs) provide an efficacious and relatively safe means by which
chemotherapeutic agents can be specifically targeted to cancer cells. In addition to the …

[HTML][HTML] Common proprotein convertase subtilisin/kexin type 9 (PCSK9) epitopes mediate multiple routes for internalization and function

RM DeVay, L Yamamoto, DL Shelton, H Liang - PloS one, 2015 - journals.plos.org
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a soluble protein that directs
membrane-bound receptors to lysosomes for degradation. In the most studied example of this, …

Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial.

…, VCSA Filho, CM Hendrickson, RM DeVay, M Donne… - medRxiv, 2023 - medrxiv.org
OBJECTIVES: Disulfiram, a low-cost generic drug used for alcohol dependence, holds the
potential to mitigate disease progression in patients with moderate COVID-19 by targeting …

A multi-phenotype system to discover therapies for age-related dysregulation of the immune response to viral infections

…, L Nicolaisen, M Donne, C Marsh, RM DeVay… - bioRxiv, 2020 - biorxiv.org
Age-related immune dysregulation contributes to increased susceptibility to infection and
disease in older adults. We combined high-throughput laboratory automation with machine …